vs

Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and 908 Devices Inc. (MASS). Click either name above to swap in a different company.

908 Devices Inc. is the larger business by last-quarter revenue ($17.4M vs $13.8M, roughly 1.3× CB Financial Services, Inc.). On growth, 908 Devices Inc. posted the faster year-over-year revenue change (21.2% vs 19.9%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $1.3M). Over the past eight quarters, 908 Devices Inc.'s revenue compounded faster (53.0% CAGR vs 1.2%).

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

908 Devices Inc. develops and manufactures portable, high-performance mass spectrometry devices and analytical solutions. Its products serve use cases across life science research, biopharmaceutical manufacturing, public safety, forensics, and industrial process monitoring, catering to global customers including research institutions, pharmaceutical firms and government agencies.

CBFV vs MASS — Head-to-Head

Bigger by revenue
MASS
MASS
1.3× larger
MASS
$17.4M
$13.8M
CBFV
Growing faster (revenue YoY)
MASS
MASS
+1.3% gap
MASS
21.2%
19.9%
CBFV
More free cash flow
CBFV
CBFV
$15.8M more FCF
CBFV
$17.2M
$1.3M
MASS
Faster 2-yr revenue CAGR
MASS
MASS
Annualised
MASS
53.0%
1.2%
CBFV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBFV
CBFV
MASS
MASS
Revenue
$13.8M
$17.4M
Net Profit
$4.2M
Gross Margin
52.7%
Operating Margin
38.1%
17.8%
Net Margin
24.0%
Revenue YoY
19.9%
21.2%
Net Profit YoY
121.5%
EPS (diluted)
$0.90
$0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBFV
CBFV
MASS
MASS
Q4 25
$13.8M
$17.4M
Q3 25
$2.4M
$14.0M
Q2 25
$13.5M
$13.0M
Q1 25
$12.1M
$11.8M
Q4 24
$13.2M
$14.3M
Q3 24
$12.7M
$14.5M
Q2 24
$12.2M
$11.5M
Q1 24
$13.5M
$7.4M
Net Profit
CBFV
CBFV
MASS
MASS
Q4 25
$4.2M
Q3 25
$-5.7M
$-15.0M
Q2 25
$3.9M
$-13.3M
Q1 25
$1.9M
$43.6M
Q4 24
$-19.4M
Q3 24
$3.2M
$-29.3M
Q2 24
$2.6M
$-12.5M
Q1 24
$4.2M
$-10.9M
Gross Margin
CBFV
CBFV
MASS
MASS
Q4 25
52.7%
Q3 25
52.5%
Q2 25
48.9%
Q1 25
47.0%
Q4 24
46.5%
Q3 24
53.6%
Q2 24
53.8%
Q1 24
52.4%
Operating Margin
CBFV
CBFV
MASS
MASS
Q4 25
38.1%
17.8%
Q3 25
-289.8%
-116.6%
Q2 25
35.0%
-116.3%
Q1 25
19.3%
-93.6%
Q4 24
23.1%
-116.8%
Q3 24
31.2%
-168.7%
Q2 24
26.4%
-74.5%
Q1 24
37.9%
-102.5%
Net Margin
CBFV
CBFV
MASS
MASS
Q4 25
24.0%
Q3 25
-235.2%
-107.0%
Q2 25
29.3%
-102.1%
Q1 25
15.8%
370.2%
Q4 24
-135.6%
Q3 24
25.3%
-201.8%
Q2 24
21.8%
-109.5%
Q1 24
31.1%
-147.1%
EPS (diluted)
CBFV
CBFV
MASS
MASS
Q4 25
$0.90
$0.09
Q3 25
$-1.07
$-0.41
Q2 25
$0.74
$-0.37
Q1 25
$0.35
$1.23
Q4 24
$0.45
$-0.58
Q3 24
$0.60
$-0.84
Q2 24
$0.51
$-0.37
Q1 24
$0.82
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBFV
CBFV
MASS
MASS
Cash + ST InvestmentsLiquidity on hand
$31.7M
$113.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.5M
$143.7M
Total Assets
$1.5B
$190.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBFV
CBFV
MASS
MASS
Q4 25
$31.7M
$113.0M
Q3 25
$55.9M
$112.1M
Q2 25
$64.5M
$118.6M
Q1 25
$61.3M
$124.3M
Q4 24
$49.6M
$69.6M
Q3 24
$147.3M
$71.7M
Q2 24
$142.6M
$77.4M
Q1 24
$73.7M
$134.2M
Stockholders' Equity
CBFV
CBFV
MASS
MASS
Q4 25
$157.5M
$143.7M
Q3 25
$152.5M
$136.3M
Q2 25
$148.4M
$148.8M
Q1 25
$148.3M
$159.4M
Q4 24
$147.4M
$114.6M
Q3 24
$149.1M
$131.0M
Q2 24
$142.9M
$156.4M
Q1 24
$141.6M
$156.9M
Total Assets
CBFV
CBFV
MASS
MASS
Q4 25
$1.5B
$190.1M
Q3 25
$1.5B
$190.9M
Q2 25
$1.5B
$191.7M
Q1 25
$1.5B
$196.0M
Q4 24
$1.5B
$159.5M
Q3 24
$1.6B
$178.3M
Q2 24
$1.6B
$208.8M
Q1 24
$1.5B
$189.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBFV
CBFV
MASS
MASS
Operating Cash FlowLast quarter
$17.8M
$1.3M
Free Cash FlowOCF − Capex
$17.2M
$1.3M
FCF MarginFCF / Revenue
124.1%
7.6%
Capex IntensityCapex / Revenue
4.7%
0.0%
Cash ConversionOCF / Net Profit
0.32×
TTM Free Cash FlowTrailing 4 quarters
$29.5M
$-24.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBFV
CBFV
MASS
MASS
Q4 25
$17.8M
$1.3M
Q3 25
$4.6M
$-4.2M
Q2 25
$4.1M
$-5.8M
Q1 25
$4.0M
$-15.0M
Q4 24
$6.8M
$-2.2M
Q3 24
$3.1M
$-5.6M
Q2 24
$-1.2M
$-13.0M
Q1 24
$3.3M
$-9.4M
Free Cash Flow
CBFV
CBFV
MASS
MASS
Q4 25
$17.2M
$1.3M
Q3 25
$4.5M
$-4.9M
Q2 25
$3.9M
$-5.9M
Q1 25
$3.9M
$-15.2M
Q4 24
$3.4M
$-2.4M
Q3 24
$2.2M
$-5.8M
Q2 24
$-2.4M
$-13.7M
Q1 24
$2.3M
$-10.3M
FCF Margin
CBFV
CBFV
MASS
MASS
Q4 25
124.1%
7.6%
Q3 25
186.5%
-34.9%
Q2 25
28.8%
-45.3%
Q1 25
32.5%
-128.9%
Q4 24
26.0%
-17.0%
Q3 24
17.4%
-39.7%
Q2 24
-19.6%
-119.4%
Q1 24
17.0%
-138.2%
Capex Intensity
CBFV
CBFV
MASS
MASS
Q4 25
4.7%
0.0%
Q3 25
4.3%
4.9%
Q2 25
1.9%
0.9%
Q1 25
0.8%
1.4%
Q4 24
25.1%
1.3%
Q3 24
6.7%
1.1%
Q2 24
10.0%
5.6%
Q1 24
7.2%
12.2%
Cash Conversion
CBFV
CBFV
MASS
MASS
Q4 25
0.32×
Q3 25
Q2 25
1.05×
Q1 25
2.11×
-0.34×
Q4 24
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBFV
CBFV

Segment breakdown not available.

MASS
MASS

Products$14.3M82%
Services$3.0M18%

Related Comparisons